Citius Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 40,283 | $20,141 | -95.68% | 0.02% |
| IFP ADVISORS, INC | 02/04/2025 | 33,333 | $4,450 | 0.00% | 0.02% |
| RONALD BLUE TRUST, INC. | 01/22/2025 | 3,000 | $1,502 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 0 | $0 | -100.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BLAIR WILLIAM & CO/IL | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 02/06/2025 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CHELSEA COUNSEL CO | 02/27/2025 | 0 | $0 | -100.00% | 0.00% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 0 | $0 | -100.00% | 0.00% |
| LPL FINANCIAL LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| MILLER INVESTMENT MANAGEMENT, LP | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| FINANCIAL ENGINES ADVISORS L.L.C. | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| HIGHTOWER ADVISORS, LLC | 02/07/2025 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 01/30/2025 | 0 | $0 | -100.00% | 0.00% |
| PRIVATE ADVISOR GROUP, LLC | 02/03/2025 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ARMISTICE CAPITAL, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SQUAREPOINT OPS LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 02/10/2025 | 0 | $0 | -100.00% | 0.00% |
| CSENGE ADVISORY GROUP | 01/30/2025 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ASPIRE PRIVATE CAPITAL, LLC | 01/17/2025 | 0 | $0 | -100.00% | 0.00% |
| PRINCETON GLOBAL ASSET MANAGEMENT LLC | 01/24/2025 | 0 | $0 | -100.00% | 0.00% |
| 01/31/2025 | 0 | $0 | -100.00% | 0.00% | |
| ARKADIOS WEALTH ADVISORS | 01/15/2025 | 0 | $0 | -100.00% | 0.00% |
| INSPIRE ADVISORS, LLC | 02/07/2025 | 0 | $0 | -100.00% | 0.00% |
| HORST & GRABEN WEALTH MANAGEMENT LLC | 01/24/2025 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| KESTRA ADVISORY SERVICES, LLC | 02/10/2025 | 0 | $0 | -100.00% | 0.00% |
| WEALTH ADVISORY SOLUTIONS, LLC | 02/06/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Citius Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 62 institutional investors and hedge funds held shares of Citius Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Ronald Blue Trust, Inc.: 0
ADVISOR GROUP HOLDINGS, INC.: 40,283
IFP Advisors, Inc: 33,333
Csenge Advisory Group: 0
CHELSEA COUNSEL CO: 0
KEYNOTE FINANCIAL SERVICES LLC: 0
0.04% of Citius Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.28 M shares in the last 24 months. This purchase volume represents approximately $1.90 M in transactions.